Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) EBIT Margin Growth (1y) (2010 - 2026)

Charles River Laboratories International (CRL) EBIT Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 50.00
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 519.00
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 1,012.00
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 376.00
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -101.00
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 136.00
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 93.00
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 352.00
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 92.00
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn 224.00

Historic Data

Download Data
DateValue
Jun 27, 2026 224.00
Dec 27, 2025 -1,178.00
Sep 27, 2025 169.00
Jun 28, 2025 -508.00
Mar 29, 2025 -487.00
Dec 28, 2024 -2,984.00
Sep 28, 2024 -313.00
Jun 29, 2024 -78.00
Mar 30, 2024 -386.00
Dec 30, 2023 -178.00
Sep 30, 2023 -51.00
Jul 1, 2023 -370.00
Apr 1, 2023 3.00
Dec 31, 2022 -420.00
Sep 24, 2022 -213.00
Jun 25, 2022 422.00
Mar 26, 2022 128.00
Dec 25, 2021 279.00
Sep 25, 2021 -47.00
Jun 26, 2021 379.00